Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Allen Bach Insider Profile
4 Followers
Mark Allen Bach, CHIEF MEDICAL OFFICER at Structure Therapeutics, Inc. Sponsored ADR, holds 26.23K shares in Structure Therapeutics, Inc. Sponsored ADR (Ticker: GPCR).
Mark Allen Bach has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mark Allen Bach's holdings
Insider Roles
CHIEF MEDICAL OFFICER
Roles that Mark Allen Bach holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark Allen Bach
Mark Allen Bach's Trading History
List of latest transactions for each holding click on a transaction to see Mark Allen Bach's performance on stock
You May Also Like
Mark Allen Bach insider profile FAQ
What is the percentage of profitable transactions made by Mark Allen Bach?
The percentage of profitable transactions made by Mark Allen Bach is ―.
What is the average return per transaction made by Mark Allen Bach?
The average return per transaction made by Mark Allen Bach is ―.
What stocks does Mark Allen Bach hold?
Mark Allen Bach holds: GPCR stocks.
What was Mark Allen Bach’s latest transaction?
Mark Allen Bach latest transaction was an Uninformative Buy of ―.
What was Mark Allen Bach's most profitable transaction?
Mark Allen Bach’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Allen Bach's role in Structure Therapeutics, Inc. Sponsored ADR?
Mark Allen Bach's role in Structure Therapeutics, Inc. Sponsored ADR is CHIEF MEDICAL OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.